Brinavess

Țară: Noua Zeelandă

Limbă: engleză

Sursă: Medsafe (Medicines Safety Authority)

Ingredient activ:

Vernakalant hydrochloride 20 mg/mL Equivalent to 18.1 mg/mL of vernakalant

Disponibil de la:

Merck Sharp & Dohme (New Zealand) Limited

INN (nume internaţional):

Vernakalant hydrochloride 20 mg/mL (Equivalent to 18.1 mg/mL of vernakalant)

Dozare:

20 mg/mL

Forma farmaceutică:

Concentrate for infusion

Compoziție:

Active: Vernakalant hydrochloride 20 mg/mL Equivalent to 18.1 mg/mL of vernakalant Excipient: Citric acid monohydrate Sodium chloride Sodium hydroxide Water for injection

Unități în pachet:

Vial, glass, Type I with 20 mm chlorobutyl rubber stupper and 20 mm Al overseal with plastic flip off cap, 30 mL, 25 mL

Clasă:

Prescription

Tip de prescriptie medicala:

Prescription

Produs de:

Merck & Cie

Indicații terapeutice:

Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults · For non-surgery patients: atrial fibrillation less than or equal to 7 days duration · For post-cardiac surgery patients: atrial fibrillation less than or equal to 3 days duration

Rezumat produs:

Package - Contents - Shelf Life: Vial, glass, Type I with 20 mm chlorobutyl rubber stupper and 20 mm Al overseal with plastic flip off cap, 30 mL - 25 mL - 36 months from date of manufacture stored at or below 30°C

Data de autorizare:

2009-11-12